Leader in cancer treatment and prevention research honored
...om its earliest preclinical and clinical stages of drug development to definitive, randomized controlled trials. His laboratory and clinical research has emphasized the chemoprevention and treatment of such pervasive and potentially deadly diseases as breast, colon, ovarian, and skin cancer." Beginning i...Student science contest participation influences study, career choices, alumni say
...is fundamental research could eventually lead to a drug that would induce weight loss in obese people, Desbiens said. Learning both the lab skills from professionals and how to explain her project and the science behind it to people who didn't have a technical background are among two of the im...Landmark gene agreement announced by Samoan government and UC Berkeley for anti-AIDS drug Prostratin
...indigenous tree the gene for a promising anti-AIDS drug and to share any royalties from sale of a gene-derived drug with the people of Samoa. The agreement, announced today (Thursday, Sept. 30) in Apia, the capital o...Landmark agreement between Samoa and UC Berkeley could help search for AIDS cure
...indigenous tree the gene for a promising anti-AIDS drug and to share any royalties from sale of a gene-derived drug with the people of Samoa. The agreement, announced today (Thursday, Sept. 30) in Apia, the capital o...New study shows hope for treating inhalant abuse
...ave previously had access to a drug, even when the drug is absent -- is similar to the aversion seen in Br... Inhalant abuse is among the most common forms of drug abuse, particularly among pre- and early adolescents, who inhale or "huff" chemical vapors found in ...NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
...ich yielded the surprising result that Orlistat, a drug approved by the FDA for treatment of obesity, inhibited prostate cancer. The Center on Proteolytic Pathways is the newest plank in the Burnham Institute's Drug Discovery Initiative, the Institute's commitment to building up the intellectual and instr...International study findings link acne-like rash to effectiveness of new targeted cancer treatment
... Administration in the USA for use with the cancer drug irinotecan for colorectal cancer that has failed other treatments. It is also the first monoclonal antibody targeting EGFR to have gained marketing authorisation in Europe and is now being evaluated in first-line treatment of colorectal cancer, with ...Belgian researchers explore revolutionary approach to angiogenesis
...ificantly increase the delivery of the anti-cancer drug cyclophosphamide to the tumour. Furthermore, tumour response to fractionated radiotherapy was also improved significantly because the increased blood flow carried more oxygen to the tumour." Dr. Feron, who is an assistant professor and research assoc...New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
... of leukaemia. It is already licensed as an orphan drug (the term for drugs intended to treat rare conditi...cer Therapeutics in Geneva that two courses of the drug achieved complete remission in over 90% of the 63 patients in a Phase II study being carried out at ...UT Southwestern biochemist honored with NIH Director's Pioneer Award
...ween circadian rhythms and depression might impact drug discovery in the treatment of potentially significant forms of mood disorder. "Taking major risks and achieving momentous accomplishments have characterized Steve McKnight's career," said Dr. Kern Wildenthal, president of UT Southwestern. "His ...Phase II trials of second-generation antisense cancer drug planned following successful early study
...ls of the first second-generation antisense cancer drug to be used in patients are soon to be underway in ...Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do. In the Phase I study the drug OGX-0...Award winning researchers reveal potential new role for Glivec
... study by an international team has shown that the drug is active against a rare type of cancer called der...encies and pharmaceutical companies by speeding up drug development while helping to implement more rational regulatory policies." Dr McArthur said that on...Trial shows which brain cancer patients benefit from temozolomide
...our biopsies to identify who will benefit from the drug could be carried out fairly easily in any genetics...se results are important because temozolomide is a drug that acts directly against DNA to slow down the replication of cancer cells. So, it is bad news if t......" is a newly fashionable field but in the world of drug development it is certainly not new, Professor Rut...t of nano-sized hybrid therapeutics and nano-sized drug delivery systems over the last decade has been remarkable. A growing number of products have already...UCSF scientist Joe Derisi named MaCarthur Fellow
...em of the organisms it invades, with an eye toward drug development." DeRisi, a faculty affili...tein, points to numerous new potential targets for drug and vaccine therapy. DeRisi is acutely aware of the need for such therapies, noting t...Evidence builds for potential new cancer drug target
...eloping cancer is reduced. "We hope to develop a drug that blocks the harmful activity of this gene in the near future. This finding was very serendipitous. We used to think c-myb was only associated with the development of leukemia but found that it's also involved in the development of breast cancer,"...Marijuana use could cause tubal pregnancies
...cent of women aged 18 to 25 said they had used the drug within the past month. The federal survey intervie... for the CB1 receptor. When the researchers gave a drug that blocked CB1 in normal mice, they observed the same phenomenon in most of the mice the embryos ...UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
...fying the synthetic molecules also may lead to new drug therapies with improved treatment options. The researchers used a scientific technique called "phage display," which is used to identify small molecule inhibitors that can disrupt interactions between proteins. According to Gregory Weiss, lead resear...Master of antimalarial resistance
... confirmed as the culprit behind resistance to the drug chloroquine in the malaria species Plasmodium falc...he discovery of pfcrt's "central role" in malarial drug resistance could "help in the development of new therapeutic strategies that are effective against c......d diagnostic tests, and helped guide the antiviral drug research. "Unfettered, free access to the results of life-science research . . . has served science and society well", the panel argues, accelerating research and speeding the "life-saving benefits" of that research'. The editorial concludes: 'But be...